Target intelligence / Profile preview

Salmonella Enteritidis O-specific polysaccharide (OPS)

Target
OPS
Molecular classification
Polysaccharide, Bacterial surface antigen, Lipopolysaccharide component
01

Overview

The Salmonella Enteritidis O-specific polysaccharide is a complex, surface-exposed carbohydrate polymer that forms the distal portion of the lipopolysaccharide (LPS) on the outer membrane of Salmonella enterica serotype Enteritidis. It consists of a repeating tetrasaccharide backbone composed of mannose, rhamnose, and galactose, uniquely substituted with the rare sugar tyvelose, which defines the serovar-specific O9 (Group D1) antigen. This molecule plays a vital role in bacterial virulence by shielding the pathogen from the host's innate immune system, specifically by preventing the assembly of the complement membrane attack complex and resisting opsonophagocytosis. In the clinical and pharmaceutical sectors, the O-specific polysaccharide is the primary target for the development of glycoconjugate vaccines aimed at preventing salmonellosis and invasive nontyphoidal Salmonella (iNTS) disease. To overcome the inherent poor immunogenicity of pure polysaccharides, these targets are typically chemically linked to carrier proteins such as CRM197 or flagellin to induce a robust T-cell dependent immune response and protective IgG antibodies.

Other names
O-antigenO-polysaccharideOPSSomatic O-antigenSalmonella Enteritidis lipopolysaccharide O-antigenO-specific chainGroup D1 O-antigenO9 antigen
02

Mechanism of action

Stimulation of active immunity leading to the production of opsonizing IgG antibodies that enhance bacterial clearance by macrophages.

03

Biological functions

Bacterial virulenceImmune evasionComplement resistanceBiofilm formationCell wall organizationEnvironmental persistence
04

Disease associations

InfectionGastroenteritisSalmonellosisInvasive nontyphoidal Salmonella (iNTS) diseaseFood poisoningBacteremia
05

Safety considerations

Risk of endotoxicity if Lipid A is present in the preparationWeak immunogenicity as a standalone T-cell independent antigenPotential cross-reactivity between related Salmonella serogroups
06

Interacting drugs

Salmonella Enteritidis O-polysaccharide conjugate vaccine

2 more in the full profile.

07

Biomarkers

Anti-O-antigen IgG antibody levelsSalmonella serogroup D1 classificationO-serotyping

Beyond the preview

Go deeper on Salmonella Enteritidis O-specific polysaccharide (OPS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella Enteritidis O-specific polysaccharide (OPS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call